Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Safety, Usability, and Effectiveness of a Gait Exoskeleton for Children and Adolescents With Neurodevelopmental Disorders.

Neurodevelopmental disorders often result in abnormal development of the Central Nervous System (CNS), frequently causing motor dysfunctions such as the inability to stand and walk. CLINICAL EXPLORER is a clinical-use robotic device for gait training, representing the evolution of the ATLAS 2030 exoskeleton and the EXPLORER device for home use. The aim of this study is to evaluate the safety and usability of CLINICAL EXPLORER .

Participants needed: 60
Trial details
Age: 2-17Biological sex: AllType: InterventionalSponsor: MarsiBionicsUpdated: Sep 8, 2025Locations: 2
Eligibility criteria

Age between 2 and 17 years. [+11]

Any medical contraindication for standing or walking. [+11]

Status: Recruiting

Safety and Usability of the ATLAS 2030 Exoskeleton in Pediatric Patients With Spinal Cord Injury

The goal of this clinical trial is to analyze the usability and safety of the robotic gait ATLAS 2030 in a cohort of pediatric patients with Spinal Cord Injury, with the aim of extending its indication for use to pediatric spinal cord injury

Participants needed: 20
Trial details
Age: 3-14Biological sex: AllType: InterventionalSponsor: MarsiBionicsUpdated: Aug 14, 2025Locations: 1
Eligibility criteria

Having a subacute or chronic spinal cord injury (SCI) and being clinically stabl... [+9]

Impossibility for the family to complete treatment schedule planning. [+13]

Status: Not yet recruiting

Safety and Usability of the EXPLORER Exoskeleton in Adults With Neuromuscular Diseases

Neurodevelopmental disorders frequently result in abnormal development of the Central Nervous System (CNS), often leading to motor impairments such as difficulty in standing and walking. EXPLORER is a robotic exoskeleton for gait rehabilitation, specifically designed for adults aged 18 to 85 with motor disabilities.The aim of this study is to evaluate the safety and usability of the EXPLORER for adults with motor disability.

Participants needed: 7
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: MarsiBionicsUpdated: Jun 4, 2025Locations: 1
Eligibility criteria

Weight < 100 kg. [+12]

Spasticity (MAS) = 3 in lower limbs. [+6]